羚锐制药(600285) - 2016 Q1 - 季度财报

Financial Performance - Operating revenue increased by 22.44% to CNY 340,008,666.62 year-on-year[7] - Net profit attributable to shareholders increased by 30.58% to CNY 46,574,505.18 compared to the same period last year[8] - Basic and diluted earnings per share increased by 23.38% to CNY 0.095[7] - The company reported a net profit excluding non-recurring gains and losses of CNY 51,024,684.57, up 24.31% year-on-year[7] - Operating profit for the current period was ¥58,333,414.19, representing an increase of 17.5% compared to ¥49,791,415.04 in the previous period[30] - Net profit for the current period was ¥51,615,569.22, a 25.1% increase from ¥41,255,870.40 in the previous period[30] Cash Flow - Net cash flow from operating activities decreased by 127.99% to -CNY 13,053,730.30 due to increased sales expenses[8] - Cash flow from operating activities showed a net outflow of -¥13,053,730.30, a decline from a net inflow of ¥46,636,613.44 in the previous period[35] - The net cash flow from investing activities was -54,877,169.19 RMB, a significant decline from 24,584,940.94 RMB in the prior year[39] - The net cash flow from financing activities was 20,724,439.63 RMB, compared to a negative cash flow of -29,660,544.40 RMB in the same period last year[39] Assets and Liabilities - Total assets decreased by 4.71% to CNY 2,616,024,267.34 compared to the end of the previous year[7] - Total liabilities decreased from CNY 1,019,934,579.31 to CNY 1,000,935,498.39, a decrease of about 1.9%[23] - Current assets increased from CNY 946,478,718.00 to CNY 985,092,731.77, an increase of about 4.8%[24] - Non-current assets decreased from CNY 1,798,758,446.26 to CNY 1,630,931,535.57, a decline of approximately 9.4%[24] Shareholder Information - The number of shareholders reached 45,036 at the end of the reporting period[12] - The largest shareholder, Henan Lingrui Group Co., Ltd., holds 14.92% of the shares, with 79,901,731 shares[12] - The major shareholder, Henan Lingrui Group, committed not to transfer shares for 36 months post the private placement[19] Expenses - Sales expenses increased by 47.84% to CNY 134,687,429.70 compared to the previous period[15] - Financial expenses decreased by 57.91% to CNY 1,293,338.29 due to lower loan interest rates[15] - Total operating costs increased to ¥283,361,492.05, up 21.3% from ¥233,523,870.49 in the previous period[28] Investments - Investment income dropped by 97.24% to CNY 157,606.96, primarily due to gains from the sale of available-for-sale financial assets in the previous period[16] - The company plans to issue 59,880,235 shares at CNY 8.35 per share, raising a total of CNY 500 million for marketing network construction and working capital[18]